The AHA guidelines for giving NSAIDs to heart patients
The American Heart Association (AHA) has issued new guidance discouraging the use of both COX-2 inhibitors and regular NSAIDs in patients with known heart disease or those thought to be at high risk of getting heart disease. The statement, recommends a new stepwise approach to the treatment of musculoskeletal pain in such patient. The statement says that all drugs should be used at the lowest dose necessary to control symptoms and prescribed for the shortest time possible.
In order to proceed further, you need to have an account on IDG.
Create a new account now
Registered users, you can login below to access this page.
Browse more articles in Guidelines
- AHA statement recommends lower BP targets for CAD patients
- ACC/AHA guidelines for CABG
- AHA Guidelines for CVD Prevention in Women Focus on Lifetime Risk
- American Academy of Pediatrics guidelines for Autism
- CDC Issues Guidelines for Preconception Care of Women
More Articles »